Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Adaptive Biotechnologies Corporation (ADPT)
Market Closed
17 Jul, 20:00
NASDAQ (NGS)
All
(5)
DE
(4)
US
(1)
NASDAQ (NGS)
Primary
XDUS
XMUN
XFRA
XSTU
$
22.
92
+0.82
+3.7104%
$
3.37B
Market Cap
-
P/E Ratio
-
Div Yield
3.23M
Volume
-1.38
Eps
$
22.1
Previous Close
Investors:
CE
JD
BG
+40
Analysts:
Watching
Watch
Add Transaction
Day Range
21.36
23.02
Year Range
9.96
23.15
Want to track
ADPT
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
News
Historical Data
Investors
Analysts
Adaptive Biotechnologies Corporation (ADPT) Statistics
Valuation metrics
Market Cap
3.37B
Enterprise value
3.8B
Trailing P/E (ttm)
-17.5
Forward P/E
-52.91
PEG ratio
-0.14
Price/Sales (ttm)
12.42
Price/Book (mrq)
4.12
Enterprise Value/Revenue
12.86
Enterprise Value/EBITDA
-172.44
Overview
Shares outstanding
153.78M
Float
118.71M
Shares short
8.56M
% Held by insiders
0.02%
% Held by institutions
1%
Average volume (10 days)
3.23M
Average volume (90 days)
2.06M
Price summary
52-Week low
9.96
52-Week high
23.15
Beta
2.3
50-Day moving average
18.41
200-Day moving average
15.49
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:4
Last split Date
15 Jul 2026
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
-0.17%
Operating margin
-0.16%
Operational effectiveness
Return on assets
-0.1%
Return on equity
-0.24%
Income Statement
Revenue (ttm)
276.98M
Revenue per share (ttm)
7.6
Quarterly revenue growth (yoy)
0.51%
Gross profit (ttm)
205.62M
EBITDA
-39.29M
Net income to common (ttm)
-59.5M
Diluted EPS (ttm)
-1.28
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
226.98M
Total cash per share (mrq)
5.62
Total debt (mrq)
210.36M
Total Debt/Equity (mrq)
0.96
Current ratio (mrq)
3.35%
Book value per share (mrq)
5.77
Cash Flow
Cash flow statement
-45.99M
Levered free cash flow (LFCF)
950.88K